ApiFix
Daphna Zaaroor Regev, Ph.D, serves as the Global Scientific and Clinical Affairs Director at OrthoPediatrics since May 2022 and has been the Director of Clinical Affairs at ApiFix, an OrthoPediatrics company, since December 2016. Prior roles include Clinical Affairs Manager at Lumenis from February 2015 to November 2016 and Scientific Manager R&D at Enzymotec from November 2009 to 2015. Daphna completed a Ph.D. in Biochemistry focused on the ubiquitin system at the Technion - Israel Institute of Technology from 2003 to 2009 and holds a B.Sc. in Biology from Ben-Gurion University of the Negev. Additional education includes a Regulatory Affairs Certificate in Medical Devices from the Regulatory Affairs Professionals Society (2019-2020) and studies at Tel Aviv University and the University of Haifa in 2018 and 2013-2014, respectively.
This person is not in any teams
ApiFix
ApiFix minimally invasive scoliosis correction system is aimed to treat patients suffering from Adolescent Idiopathic Scoliosis (AIS) that are classified as Lenke Type 1 or and Type 5, having with a Cobb angle from 35 to 55 degrees.Unlike the traditional scoliosis correction operation that tries attempts to fix the deformity in one aggressiveand complex operation, the ApiFix system is based on a minimal surgical intervention and a correction process that spans over several months, with the aid of unique physical therapy.